Objective: This study concerns expression of PBK/TOPK during differentiation of HL-60 leukemic cellsinduced by tetradecanoyl phorbol acetate (TPA). Methods: Wright-Giemsa staining was performed to observemorphological changes in the HL-60 cells, and flow cytometry was used to assess the cell cycle and CD11b,CD14, CD13, and CD33 expression. PBK/TOPK levels were determined by Western blot analysis. Results: Aftertreating HL60 cells with 5.1 × 10-9 mmol/L of TPA for three days, the number of nitroblue-tetrazolium-positivecells and CD11b, CD13, and CD14 expression increased, whereas the PBK/TOPK levels decreased. Conclusions:TPA can inhibit proliferation and induce differentiation of HL60 cells of the granulocytic or monocytic lineage.PBK/TOPK expression was downregulated during this process, whereas the Pho-PBK/TOPK expression wasincreased.
(2012). PBK/TOPK Expression During TPA-Induced HL-60 Leukemic Cell Differentiation. Asian Pacific Journal of Cancer Prevention, 13(5), 2145-2148.
MLA
. "PBK/TOPK Expression During TPA-Induced HL-60 Leukemic Cell Differentiation". Asian Pacific Journal of Cancer Prevention, 13, 5, 2012, 2145-2148.
HARVARD
(2012). 'PBK/TOPK Expression During TPA-Induced HL-60 Leukemic Cell Differentiation', Asian Pacific Journal of Cancer Prevention, 13(5), pp. 2145-2148.
VANCOUVER
PBK/TOPK Expression During TPA-Induced HL-60 Leukemic Cell Differentiation. Asian Pacific Journal of Cancer Prevention, 2012; 13(5): 2145-2148.